Blood Purification Equipment Market Report 2025

The blood purification equipment market size has grown strongly in recent years. It will grow from $20.71 billion in 2024 to $21.98 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased renal diseases, aging population, government initiatives, growing ICU admissions, rising chronic conditions.

The blood purification equipment market size is expected to see strong growth in the next few years. It will grow to $31.15 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to home-based dialysis solutions, focus on cost-effectiveness, renal replacement therapies innovation, personalized treatment, regulatory support. Major trends in the forecast period include personalized medicine approaches, enhanced connectivity, collaborations and partnerships, expanded applications, multi-modal therapies.

The growing number of kidney transplants is expected to drive the expansion of the blood purification equipment market in the future. A kidney transplant involves a surgical procedure where a healthy kidney from a donor is implanted into a patient suffering from end-stage renal disease (ESRD) or other severe kidney disorders. Blood purification equipment plays a crucial role in managing these patients by eliminating excess medications from the bloodstream, maintaining electrolyte balance, and regulating fluid levels. For instance, in July 2023, the National Health Service (NHS), a UK-based government department, reported an 18% increase in deceased organ donors and a 27% rise in organ transplants in 2022/23 compared to 2021/22. Therefore, the increase in kidney transplants is driving growth in the blood purification equipment market.

The rising incidence of metabolic and immune disorders is anticipated to drive the growth of the blood purification equipment market in the future. Autoimmune disorders, or immune disorders, occur when the body's immune system mistakenly attacks and destroys healthy tissues, such as those in the kidneys. On the other hand, metabolic disorders arise from abnormal chemical reactions that disrupt the body’s natural metabolism. Conditions like insulin resistance, obesity, and hypertension contribute to the development of acute kidney injury, diabetes, chronic kidney injury, and other related issues that necessitate blood filtration through artificial equipment due to a rapid decline in kidney function. For example, in March 2022, the International Diabetes Federation, a Belgium-based non-profit organization, projected that the global prevalence of diabetes would rise from 643 million in 2030 to 783 million by 2045, adding 140 million cases. Thus, the increasing prevalence of metabolic and immune disorders is driving the growth of the blood purification equipment market.

Major companies in the market are focusing on innovation in response to the growing demand for blood purification therapy. An example is Santersus AG, a therapeutic apheresis company, which received FDA breakthrough designation for its medical device product, NucleoCapture, in June 2022. NucleoCapture is designed to cleanse patient blood of neutrophil extracellular traps (NETs), recognized as contributors to conditions such as sepsis. This innovative product represents a significant advancement in capturing and removing circulating NETs from patient blood, addressing the need for safe and effective NET removal without compromising neutrophil function. The development of such innovative products showcases the commitment of industry leaders to meet the evolving demands in blood purification therapy.

Major companies in the blood purification equipment market are focusing on developing technologies like large-bore aspiration systems to enhance the efficiency and effectiveness of blood purification processes, improve patient outcomes, and minimize procedural complications. A large-bore aspiration system is a medical device specifically designed to efficiently extract large volumes of fluid or debris from the body during minimally invasive procedures. For example, in September 2024, Argon Medical Devices, a US-based manufacturer of medical devices, introduced the CLEANER Vac Thrombectomy System. This disposable, large-bore aspiration system facilitates rapid and effective thrombus removal, particularly in vessels with restricted blood flow. The system provides physicians with manual control over powered aspiration, which is essential for precise clot removal, minimizing potential damage to the vessel, and reducing blood loss during procedures.

In September 2022, W. L. Gore & Associates, Inc., a US-based company specializing in products derived from fluoropolymers, acquired InnAVasc Medical, Inc. This strategic acquisition adds graft technology to Gore's dialysis access solutions. The InnAVasc device, featuring graft circuits, facilitates safe, easy, reproducible, and durable access to dialysis treatment for patients. InnAVasc Medical Inc., the acquired company, is a US-based medical equipment manufacturer with expertise in designing and developing products specifically for vascular access in hemodialysis. This move underscores the commitment of major players in the blood purification equipment market to drive innovation and enhance the efficiency and safety of blood purification processes.

Major companies operating in the blood purification equipment market include B. Braun Melsungen AG, Baxter International Inc., Nikkiso Co. Ltd., Spectra Medical Inc., Fresenius SE and Co. KGaA, Cerus Corporation, Infomed SA, Asahi Kasei Corporation, Healthwell Medical Tech. Co. Ltd., SWS Medical Group, ExThera Medical Corporation, Stellarray Inc., Medtronic, Toray Medical Co Ltd., NxStage Medical Inc., Nipro Pharma Corporation., WEGO Group, JMS Co. Ltd., Shanwaishan Medical Group, Cytosorbents Corporation, Aethlon Medical Inc., SWS Hemodialysis Care Co Ltd, Jafron Biomedical Co. Ltd., Medica S.p.A., Medivators Inc., Rockwell Medical Inc., Terumo Corporation, Belco, Spiggle & Theis Medizintechnik, Delcon.

Asia-Pacific was the largest region in the blood purification equipment market in 2024. The regions covered in the blood purification equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood purification equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Blood purification equipment comprises hollow-fiber membrane devices utilized in critical care nephrology, facilitating blood purification through processes such as diffusion, convection, and ultrafiltration. These devices filter blood by removing toxins and irreparably damaged red blood cells.

The primary product categories of blood purification equipment include portable and stationary variants. Portable equipment is designed to be moved between locations to conduct blood purification procedures, particularly beneficial for patients with limited mobility, such as those in intensive care units. This equipment is utilized to eliminate waste products and excess fluids from the blood. It finds applications across various medical indications such as sepsis, renal diseases, among others, and is predominantly used by hospitals and clinics, dialysis centers, and similar healthcare facilities.

The blood purification equipment market research report is one of a series of new reports that provides blood purification equipment market statistics, including blood purification equipment industry global market size, regional shares, competitors with a blood purification equipment market share, detailed blood purification equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the blood purification equipment industry. This blood purification equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood purification equipment market consists of sales of dialysis machines, continuous renal replacement therapy and hemodialysis devices (CRRT), in vitro diagnostics, infusion pumps, personal protective equipment, and remote or wearable patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.